Search hospitals > Missouri > Chesterfield

Saint Luke's Hospital

Claim this profile
Chesterfield, Missouri 63017
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Non-Small Cell Lung Cancer
141 reported clinical trials
3 medical researchers
Photo of Saint Luke's Hospital in ChesterfieldPhoto of Saint Luke's Hospital in ChesterfieldPhoto of Saint Luke's Hospital in Chesterfield

Summary

Saint Luke's Hospital is a medical facility located in Chesterfield, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Non-Small Cell Lung Cancer and other specialties. Saint Luke's Hospital is involved with conducting 141 clinical trials across 295 conditions. There are 3 research doctors associated with this hospital, such as Joseph Sokhn, Mark J. Fesler, and Donald F. Busiek.

Area of expertise

1Cancer
Global Leader
Saint Luke's Hospital has run 40 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Saint Luke's Hospital has run 38 trials for Breast Cancer. Some of their research focus areas include:
HER2 positive
ER positive
Stage IV

Top PIs

Clinical Trials running at Saint Luke's Hospital

Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Lymphoma
Diffuse Large B-Cell Lymphoma
Cancer
Bladder Cancer
B-Cell Lymphoma
Heart Failure
Anal Squamous Cell Carcinoma
Image of trial facility.

Radiation Therapy + Olaparib

for Breast Cancer

This study is evaluating whether radiation therapy with or without olaparib may help treat inflammatory breast cancer.
Recruiting1 award Phase 248 criteria
Image of trial facility.

Chemotherapy Reduction After Surgery

for Breast Cancer

This study is evaluating whether a combination of drugs may help treat breast cancer.
Recruiting1 award Phase 227 criteria
Image of trial facility.

Targeted Therapy

for Solid Tumors

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Saint Luke's Hospital?
Saint Luke's Hospital is a medical facility located in Chesterfield, Missouri. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Non-Small Cell Lung Cancer and other specialties. Saint Luke's Hospital is involved with conducting 141 clinical trials across 295 conditions. There are 3 research doctors associated with this hospital, such as Joseph Sokhn, Mark J. Fesler, and Donald F. Busiek.